NCCAM St. John’s Wort Studies On OCD, Social Phobia Recruiting Subjects
This article was originally published in The Tan Sheet
Executive Summary
An NCCAM-funded study on the use of St. John's wort to treat obsessive-compulsive disorder is part of an ongoing effort by researchers to find the most appropriate therapeutic applications for the botanical, Duke University's Jonathan Davidson, MD, said at the NIH center's advisory council meeting May 28You may also be interested in...
Inconclusive St. John’s Wort Trial Prompts Queries On Study Design, Setting
The inconclusive nature of a recent study on St. John's wort suggests the current procedure for funding and designing clinical trials of botanicals may need to be reexamined, according to a letter in the July 24 Journal of the American Medical Association
Inconclusive St. John’s Wort Trial Prompts Queries On Study Design, Setting
The inconclusive nature of a recent study on St. John's wort suggests the current procedure for funding and designing clinical trials of botanicals may need to be reexamined, according to a letter in the July 24 Journal of the American Medical Association
Inconclusive St. John’s Wort Trial Prompts Queries On Study Design, Setting
The inconclusive nature of a recent study on St. John's wort suggests the current procedure for funding and designing clinical trials of botanicals may need to be reexamined, according to a letter in the July 24 Journal of the American Medical Association
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports
New to Pink Sheet?
Start a free trial today!
Register for our free email digests:
Register for our free email digests: